Clinical use of Abemaciclib a cyclin-dependent kinase (CDK) 4/6 inhibitor in patients with breast cancer - literature review

• Main Authors: Katarzyna Maria Krukar (Author), Martyna Pustelniak (Author), Katarzyna Rudnicka (Author), Ilona Sajkiewicz (Author), Nadia Miga-Orczykowska (Author), Ilona Jasiuk (Author), Justyna Wójtowicz (Author), Paulina Lemieszek (Author), Ewa Łukaszewska (Author), Klaudia Kister (Author), Kamil Chrościński (Author), Jakub Laskowski (Author)
• Format: Book
• Published: Kazimierz Wielki University, 2024-09-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Breast cancer is the most common neoplasma affecting women. Over, the past few years, the incidence of breast cancer has significantly increased, including among young women. Hormone receptor-positive (HR+) Her2 negative (HER2-) early stage breast cancer can be successfully treated using the current...